XM does not provide services to residents of the United States of America.
A
A

AalbertsIndustries

Trade Ideas

Traders Sentiment

Technical Summary

Hourly

News

Allianz, Carnival, Future

EUROPE RESEARCH ROUNDUP-Allianz, Carnival, Future June 4 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including Allianz, Carnival and Future, on Tuesday. HIGHLIGHTS * Allianz SE ALVG.DE : Citigroup cuts to neutral from buy * Carnival CCL.L : Peel Hunt raises to buy from add * Future Plc FUTR.L : Berenberg raises to buy from hold * Liontrust Asset Management Plc LIO.L : Deutsche Bank cuts to sell from hold * Nibe NIBEB.ST : Barclays cuts t
A
A
C
D
F
F
H
I
I
K
L
L
M
N
P
R
A
A
A
B
F
P
Z

Aalberts shares fall around 4% on revenue decline

BUZZ-Aalberts shares fall around 4% on revenue decline ** Shares in Aalberts AALB.AS fall around 4% after the industrial engineering group reported a 2.6% revenue decline in the first four months of 2024 ** This reflects weak demand, which was expected, Degroof Petercam says ** "We expect to trim our 2024 estimates to reflect the lower growth in in
A

Aalberts Four-Month Organic Revenue Falls 2.6% Year-On-Year

BRIEF-Aalberts Four-Month Organic Revenue Falls 2.6% Year-On-Year May 22 (Reuters) - Aalberts NV AALB.AS : IN FIRST FOUR MONTHS AALBERTS REALISED -2.6% ORGANIC REVENUE GROWTH COMPARED TO LAST YEAR Source text for Eikon: ID:nGNX1XjbD1 Further company coverage: AALB.AS (Gdansk Newsroom)
A

Degroof Petercam ups Aalberts to 'buy' on growth and M&A prospects

BUZZ-Degroof Petercam ups Aalberts to 'buy' on growth and M&A prospects ** Degroof Petercam raises Aalberts AALB.AS to "buy" from "hold", saying the industrial engineering group should return to growth in 2025 while potential M&A deals should boost earnings ** Aalberts' 2023 results showed it can protect margins even in tough conditions, the broker
A

Aston Martin, Bodycote, Systemair

EUROPE RESEARCH ROUNDUP- Aston Martin, Bodycote, Systemair March 18 (Reuters) - Securities analysts revised their ratings and price targets on several European companies including Aston Martin, Bodycote, and Systemair, on Monday. HIGHLIGHTS * Aston Martin AML.L : Jefferies cuts target price to 275p from 330p * Bodycote Plc BOY.L : JP Morgan raises target price to 620p from 600p * Novo Nordisk NOVOb.CO : Berenberg raises target price to DKK 900 from DKK 850 * Systemair AB SYSR.ST : Jefferies rais
A
A
A
A
A
B
B
B
B
C
C
C
C
D
E
E
E
G
H
I
L
L
P
P
S
A
A
A
A
D
P
U

Conditions

Popular Assets

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.